SCHEMBL1874459

SCHEMBL1874459

CCCCCCC(C)[CH]C(C)CCCC

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 2/20 0.48
OPRM1 P35372 1/20 0.46
ADH1B P00325 1/20 0.45
ADH1C P00326 1/20 0.45
ADH1A P07327 1/20 0.45
ADH4 P08319 1/20 0.45
ADH7 P40394 1/20 0.45
SPHK1 Q9NYA1 1/20 0.43
LMNA P02545 1/20 0.42
TSHR P16473 1/20 0.42
THRB P10828 1/20 0.42
CA2 P00918 1/20 0.40
ACE2 Q9BYF1 1/20 0.39
FDPS P14324 3/20 0.38
GPR84 Q9NQS5 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4273909 1.00 DNM1 (0.48) DNM1OPRM1ADH1BADH1CADH1A
SCHEMBL4276657 1.00 DNM1 (0.48) DNM1OPRM1ADH1BADH1CADH1A
SCHEMBL4269729 0.97 OPRM1 (0.48) DNM1OPRM1ADH1BADH1CADH1A
SCHEMBL4275505 0.97 OPRM1 (0.48) DNM1OPRM1ADH1BADH1CADH1A
SCHEMBL4275310 0.97 OPRM1 (0.48) DNM1OPRM1ADH1BADH1CADH1A
SCHEMBL4275203 0.97 OPRM1 (0.48) DNM1OPRM1ADH1BADH1CADH1A
SCHEMBL4277169 0.97 OPRM1 (0.48) DNM1OPRM1ADH1BADH1CADH1A
SCHEMBL4281820 0.97 OPRM1 (0.48) DNM1OPRM1ADH1BADH1CADH1A
SCHEMBL4272101 0.97 OPRM1 (0.48) DNM1OPRM1ADH1BADH1CADH1A
SCHEMBL3966507 0.97 OPRM1 (0.48) DNM1OPRM1ADH1BADH1CADH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10230023-B2 Color converter BASF SE (DE) 2019-03-12 US disclosed
EP-2718395-B1 Novel illumination device comprising a colour converter BASF SE (DE) 2018-02-28 EP disclosed
CN-103619987-B Color converter 巴斯夫欧洲公司 2016-11-16 CN disclosed
US-20160284947-A1 NOVEL COLOR CONVERTER BASF SE (DE) 2016-09-29 US disclosed
US-9406848-B2 Color converter BASF SE (DE) 2016-08-02 US disclosed
EP-2718395-A1 NOVEL COLOR CONVERTER BASF SE (DE) 2014-04-16 EP disclosed
CN-103619987-A Novel color converter BASF SE 2014-03-05 CN disclosed
WO-2012168395-A1 NOVEL COLOR CONVERTER BASF SE (DE) 2012-12-13 WO disclosed
US-7935322-B2 Solvent extraction process for separating cobalt and/or nickel from impurities in leach solutions Commonwealth Scientific & Indistrial Research Organisation (AU) 2011-05-03 US disclosed
WO-2009037283-A1 METHOD FOR PRODUCING SUBSTRATES COATED WITH RYLENE TETRACARBOLIC ACID DIIMIDES BASF SE (DE) 2009-03-26 WO disclosed
US-20090078312-A1 VERFAHREN ZUR HERSTELLUNG VON MIT RYLENTETRACARBONSAEUREDIIMIDEN BESCHICHTETEN SUBSTRATEN BASF SE (DE) 2009-03-26 US disclosed
EP-1716262-A4 SOLVENT EXTRACTION PROCESS FOR SEPARATING COBALT AND/OR NICKEL FROM IMPURITIES IN LEACH SOLUTIONS. COMMW SCIENT IND RES ORG (AU) 2008-08-13 EP disclosed
US-20080038168-A1 Solvent Extraction Process For Separating Cobalt And/Or Manganese From Impurities In Leach Solutions COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2008-02-14 US disclosed
US-20070248514-A1 Solvent Extraction Process for Separating Cobalt and/or Nickel from Impurities in Leach Solutions COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH OR (AU) 2007-10-25 US disclosed
EP-1716262-A1 SOLVENT EXTRACTION PROCESS FOR SEPARATING COBALT AND/OR NICKEL FROM IMPURITIES IN LEACH SOLUTIONS. COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2006-11-02 EP disclosed
WO-2005073416-A1 SOLVENT EXTRACTION PROCESS FOR SEPARATING COBALT AND/OR NICKEL FROM IMPURITIES IN LEACH SOLUTIONS. COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2005-08-11 WO disclosed
WO-2005073415-A1 SOLVENT EXTRACTION PROCESS FOR SEPARATING COBALT AND/OR MANGANESE FROM IMPURITIES IN LEACH SOLUTIONS COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2005-08-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090078312-A1 VERFAHREN ZUR HERSTELLUNG VON MIT RYLENTETRACARBONSAEUREDIIMIDEN BESCHICHTETEN SUBSTRATEN AXIN2, NCSTN, NES DNM1 1249/4885OPRM1 4144/4885ADH1B 1626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.